Drugs for HER-2-positive Breast Cancer

Drugs for HER-2-positive Breast Cancer

Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors. With implementation of the growth-inhibitory...

Full description

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Sibilia, Maria (Editor), Zielinski, Christoph C. (Editor), Bartsch, Rupert (Editor), Grunt, Thomas W. (Editor)
Format: Electronic eBook
Language:English
Published: Basel : Springer Basel, 2011.
Series:Milestones in Drug Therapy
Subjects:
Medicine.
Cancer research.
Immunology.
Antibodies.
Pharmacology.
Internal medicine.
Oncology.
Biomedicine.
Pharmacology/Toxicology.
Cancer Research.
Internal Medicine.
Online Access:Full Text via HEAL-Link

Internet

Full Text via HEAL-Link

ΒΚΠ - Πατρα: ALFd

Holdings details from ΒΚΠ - Πατρα: ALFd
Call Number: 330.01 BAU
Copy 1 Available

ΒΚΠ - Πατρα: BSC

Holdings details from ΒΚΠ - Πατρα: BSC
Call Number: 330.01 BAU
Copy 2 Available
Copy 3 Available

Similar Items